High-throughput crystallographic fragment screening of Zika virus NS3 Helicase.
Preprint
Godoy AS. et al, (2024)
A selection of Golden Gate vectors to simplify recombinant protein production inEscherichia coli
Preprint
Fairhead M. et al, (2024)
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Journal article
Boby ML. et al, (2023), Science, 382
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search.
Journal article
Wills S. et al, (2023), J Chem Inf Model
Turning high-throughput structural biology into predictive inhibitor design.
Journal article
Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors.
Journal article
Schuller M. et al, (2023), Pathogens, 12
CoPriNet: graph neural networks provide accurate and rapid compound price prediction for molecule prioritisation
Journal article
Sanchez-Garcia R. et al, (2023), Digital Discovery
Fragment Libraries Designed to Be Functionally Diverse Recover Protein Binding Information More Efficiently Than Standard Structurally Diverse Libraries
Journal article
Carbery A. et al, (2022), Journal of Medicinal Chemistry
Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2.
Journal article
Gahbauer S. et al, (2022), bioRxiv
SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction.
Journal article
Grosjean H. et al, (2022), J Comput Aided Mol Des
Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main protease.
Journal article
Bray S. et al, (2022), J Cheminform, 14
Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors
Journal article
Osipov EM. et al, (2022), RSC Chemical Biology
Turning high-throughput structural biology into predictive inhibitor design
Preprint
Saar K. et al, (2021)
There is no market for new antibiotics: this allows an open approach to research and development
Preprint
Klug D. et al, (2021)
Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.
Journal article
Mackinnon SR. et al, (2021), ACS Chem Biol, 16, 586 - 595
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.
Journal article
Schuller M. et al, (2021), Sci Adv, 7